The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial - G.M. Goodwin; Scott T. Aaronson; Boadie W. Dunlop; David Feifel; David J. Hellerstein; N. Hewitt; L. Marwood; S. Mistry; Metten Somers; S.C. Stansfield; J. Tsai; S. Williams; et al. (Neuroscience Applied, 2021)